Document:

CONSULTING
SERVICES AGREEMENT dated as of November 7, 2018 (this “Agreement”), effective November 1, 2018 (“Effective Date”)
by and between:

 

(1)
Alexandre Mencik Enterprise, a company incorporated in Belgium, with its registered office Avenue des Genêts/Ginstlaan
31, B-1640 Rhode-Saint-Genèse/Sint-Genesius-Rode, identification number BE067.806.963 (“the Chief Business Officer”);
and

 

(2)
Vector Therapeutics Inc. (ex-Oxygen Therapy, Inc) (“Vector Therapeutics”), a Delaware corporation with an Chief
Business Officer office 85 Broad Street, 27 Floor, New York 10004, USA and its registered office in the State of Delaware, 160
Greentree Drive # 101, in the City of Dover, Country of Kent, 19904 USA, duly represented by Dr. Daniel Teper (“Company”)

 

The
Chief Business Officer and Company are also sometimes herein referred to collectively as the “Parties” and each individually
as a “Party”.

 

WHEREAS,
Company is engaged in development, manufacturing and distribution of medicinal products.

 

WHEREAS,
Chief Business Officer and General Counsel possesses the requisite skills, expertise and experience to perform its obligations
under this Agreement;

 

WHEREAS,
Company desires to avail itself of the services of Chief Business Officer and General Counsel upon the terms, provisions and conditions
hereinafter set forth and Chief Business Officer and General Counsel declares to be prepared to render such services to
Company on the terms, provisions and conditions set forth hereinafter and declares to be capable thereof.

 

NOW
THEREFORE, in consideration of agreements of the Parties set forth herein and other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the Parties agree as follows:

 

Section
1. Consultancy. The Company hereby appoints, retains and engages the Chief Business Officer and General Counsel of the
Company for the Term (as hereinafter defined), and the Chief Business Officer and General Counsel hereby accepts to serve as the
Company’s Chief Business Officer and General Counsel upon the terms, provisions and conditions of this Agreement.

 

Section
2. Duties. The Chief Business Officer and General Counsel shall (1) continue to serve as Founder/shareholder and Partner
(Gérand) of VectorLab GmbH and its successor or assign (with single signature power, including on the bank accounts) and
(2) shall serve as Chief Business Officer and General Counsel of Vector Therapeutics and shave a leadership role in Vector Therapeutics,
in accordance with the strategic goals set by the Board, the CEO and those having C-level positions, and be, without limitation,
the Officer primarily responsible for overseeing, identifying and managing: (i) legal/IP and compliance issues; (ii) accounting
and financial reporting; (iii) corporate and financial deals & transactions (structure and negotiations); (iv) corporate governance
and business policy; (v) government & trade association relations; and (vii) certain aspects of business development &
growth, corporate finance & stock listing (if any), regulatory & life cycle management strategies, market access &
pricing/reimbursement strategies; and daily operations (hereinafter referred to collectively as “the Services”). The
Chief Business Officer shall devote 4 days maximum per week of his time to the performance of the Services, except during the
public holidays in Belgium; provided, that Chief Business Officer and General Counsel may serve on companies outside boards and
take other consulting or advisory responsibilities.

 

Section
3. Term of Consultancy. Unless earlier terminated pursuant to the provisions of Section 5 hereof, the term of Chief Business
Officer and General Counsel’s consultancy shall commence as of the Effective Date and shall continue until August 31,
2021 and shall automatically renew for successive one (1) year terms, unless (i) the Company provides the Chief Business Officer
and General Counsel with written notice, given not less than ninety (90) days prior to the then expiration date that the Company
does not intend for the Term (as hereinafter defined) to automatically extend or , or (ii) the Chief Business Officer and General
Counsel’s provides the Company with written notice, given not less than thirty (30) days prior to the then expiration date
of the Term that the Chief Business Officer and General Counsel does not intend for the Term to automatically extend the term
of consultancy, as it may be extended, the “Term”).

 

    	 	1	 

    	 

    

 

Section
4. Compensation of Chief Business Officer and General Counsel.

 

4.1. Compensation.
As compensation for the Services, the Company shall pay Chief Business Officer and General Counsel a fixed yearly
compensation (“the Compensation”) of three hundred fifty thousand dollars ($350,000). The Compensation shall be
payable monthly at the latest within fifteen (15) days after receipt of the invoice. The Compensation is exclusive of
VAT/tax. VAT/ tax, if applicable, will be charged by Chief Business Officer and General Counsel to the Company at the
applicable rate. The Compensation may be increased (but not reduced) at Company’ own discretion, upon proposition by
the Chief Business Officer and General Counsel and in line with the recommendations of the Compensation Committee of the
Board (the “Compensation Committee”).

 

4.2. Bonus;
Stock Options.

 

(a)
In addition to the Compensation payable to the Chief Business Officer and General Counsel, the Chief Business Officer and General
Counsel shall receive an annual Bonus (the “Bonus”) of up to 50% of the Chief Business Officer and General Counsel’s
then applicable Compensation, based on the Chief Business Officer and General Counsel’s and / or the Company’s achievement
of specified performance indicators (the “Goals”), as determined by the Board or the Compensation Committee of the
Board if such a Committee is in existence. The Bonus shall be payable in cash and up to 50% in shares of the Company’s Common
Stock (the “Common Stock”), at the Chief Business Officer and General Counsel’s own discretion. The Common Stock
component of the Bonus shall be paid in a manner consistent with the Company’s Stock Award Program, if applicable. The Bonus
shall be calculated within thirty (30) days after the end of the applicable year (or after this Agreement was terminated) and
will be paid promptly thereafter, including after the Term, and including partially. The Goals for each year of the Term, other
than the initial year, shall be set by the Board no later than thirty (30) days after the commencement of the applicable annual
period. Bonus metrics for the first period (2018) will be set up as soon as possible after execution of this Agreement by the
Board and the Compensation Committee if such a Committee is in existence.

 

(b)
As additional compensation for the services hereunder, the Chief Business Officer and General Counsel shall receive (i) as promptly
as possible following the Effective Date, 400,000 shares of the Company’s Common Stock of the Company; and (ii) and a grant,
effective as of the Effective Date, Company of 300,000 Company Shares of Common Stock, with a quarterly vesting during the Term
of this Agreement, with the first 25,000 Company Shares vesting on November 30, 2018 and 25,000 Company Shares vesting on the
last day of each three month period thereafter; provided that at the vesting date the Chief Business Officer and General Counsel
is employed with the Company.

 

(c)
Subject to the approval of the Compensation Committee of the Board or the Board if there is no Compensation Committee, as applicable,
for each fiscal year during the term of his consultancy following the first fiscal year, Chief Business Officer and General Counsel
shall be eligible to receive, simultaneous with receipt of the Cash Bonus described in Section 4.2 (a), options to purchase a
number of shares of the Company’s common stock, with an aggregate fair market value to be determined following standard
methods, subject to and in accordance with the terms and provisions of the Company’s plan and the applicable award agreement.

 

(d)
Expenses. The Company shall pay or reimburse Chief Business Officer and General Counsel for all reasonable and necessary
business, travel or other expenses incurred by him (including those for services that have been rendered since March 1, 2018 and
that have not yet been reimbursed, if any), upon submission to the Company of proper documentation thereof, in accordance with
the Company’s travel and expense policy, which may be incurred by him in connection with the performance of his consultancy
services contemplated hereunder, including services rendered during the Prior Period. It is agreed that business class airfare
shall be permitted on all international travel.

 

    	 	2	 

    	 

    

 

(e)
Benefits. After the Effective Date and during the Term, the Chief Business Officer and General Counsel shall be entitled
to participate in such pension, profit sharing, group insurance, term life, option plans, hospitalization, and group health benefit
plans and all other benefits and plans as the Company provides to its senior Chief Business Officer and General Counsels, subject
to the terms and conditions of such plans, and taking into account the independent nature of the Chief Business Officer and General
Counsel.

 

(f)
Vacation. The Parties will consult with each other with a view to enable the Chief Business Officer and General Counsel
to have a reasonable number of days of paid vacation each year, preferably during the school holidays in Belgium, and in any case,
not less than four (4) weeks during each twelve (12) month of the Term, during which period his Compensation shall be paid in
full. Upon the Chief Business Officer and General Counsel’s termination of consultancy for any reason whatsoever, he shall
be entitled to payment for a maximum of 20 accrued but unused vacation days.

 

(g)
Sick Time. The Chief Business Officer and General Counsel shall be entitled to sick time in accordance with the Company’s
sick time policy.

 

5.1.
Termination. The Chief Business Officer and General Counsel’s consultancy hereunder may be terminated upon written
notice of termination to the Chief Business Officer and General Counsel from the Company and shall be immediately terminated upon
the Chief Business Officer and General Counsel’s death or immediately in the case of termination by the Chief Business Officer
and General Counsel . The Chief Business Officer and General Counsel’s consultancy hereunder may be terminated for the following
reasons: (i) the Chief Business Officer and General Counsel’s death or Total Disability (as hereinafter defined ); or (ii)
termination of the Chief Business Officer and General Counsel’s consultancy for the Company For Cause (as hereinafter defined
); or (iii) termination of the Chief Business Officer and General Counsel’s consultancy for the Company other than For Cause;
or (iv) a Change in Control Termination (as hereinafter defined ); or (v) termination of the Chief Business Officer and General
Counsel’s consultancy by the Chief Business Officer and General Counsel without Good Reason (as hereinafter defined); or
(vi) termination of the Chief Business Officer and General Counsel’s consultancy by the Chief Business Officer and General
Counsel for Good Reason.

 

5.2.
Termination upon Death or Total Disability. The Chief Business Officer and General Counsel’s consultancy shall terminate
immediately upon the Chief Business Officer and General Counsel’s death or upon written notice of termination to the Chief
Business Officer and General Counsel of a termination due to Total Disability. In the event of a termination upon the death or
Total Disability of the Chief Business Officer and General Counsel, the Company shall pay to Chief Business Officer and General
Counsel, or any person designated by Chief Business Officer and General Counsel in writing or, if no such person is designated,
to his estate, the Compensation which has been earned but unpaid. As used herein, the term “Total Disability” shall
mean that Chief Business Officer and General Counsel is unable to engage in any substantial way in the performance of his duties
for the Company by reason of any medically determinable physical or mental impairment which can be expected to result in death
or which has lasted, or can be expected to last, for a continuous period of not less than one year as substantiated by a written
report by a competent physician engaged by the Company who is reasonably acceptable to the Chief Business Officer and General
Counsel or his representative.

 

    	 	3	 

    	 

    

 

5.3.
Termination For Cause or without Good Reason. In the event the Chief Business Officer and General Counsel s consultancy
is terminated by the Company For Cause or by the Chief Business Officer and General Counsel without Good Reason, the Company shall
be obligated to pay the Chief Business Officer and General Counsel his Compensation through the date of termination. As used herein,
the term “For Cause” shall mean (i) a court of competent jurisdiction has made a final determination of Chief Business
Officer and General Counsel’s misappropriation of the Company’s assets or perpetration of fraud or willful malfeasance
in his dealings with or on behalf of the Company; (ii) the Chief Business Officer and General Counsel’s plea of guilty or
nolo contendere to, or conviction in a court of law of, any crime or offense which constitutes a felony, in each case whether
or not involving the Company; (iii) Chief Business Officer and General Counsel’s engaging in an act of moral turpitude which
is likely to have a material adverse effect on the Company’s business or reputation; (iv) the Chief Business Officer and
General Counsel’s habitual drunkenness or habitual use of illegal substances; (v) the Chief Business Officer and General
Counsel’s failure to cooperate with a governmental or regulatory investigation concerning the Company or the Chief Business
Officer and General Counsel; (vi) the Chief Business Officer and General Counsel’s willful refusal to follow, or reckless
disregard of, the written policies and reasonable directives of the Company or the Board after given the opportunity to object
with such directive and given thirty (30) calendar days to cure; or (vii) the Chief Business Officer and General Counsel’s
material breach of a material provision of this Agreement, which material breach, if curable, is not cured within thirty (30)
calendar days after written notice thereof by the Company. Whether a termination is “For Cause,” as such term is defined
in this Section 5.3, shall be determined by a vote of at least 3⁄4 of all of the members of the Board, including Chief Business
Officer and General Counsel’s vote, in its sole discretion. Notwithstanding the foregoing, upon written notice of a material
breach that could result in a For Cause termination pursuant to clauses (vii) and /or (viii) of the preceding sentence, the Chief
Business Officer and General Counsel may upon written notice to the Company, which shall be given within five (5) business days
after receipt of the notice of material breach, request a hearing on the matter before all members of the the Board (in which
the Chief Business Officer and General Counsel may be accompanied by his own legal counsel) in order for the Chief Business Officer
and General Counsel to provide information that refutes, or justifies the actions that form, the basis of the assertion that a
material breach has occurred. If such a hearing is requested, the notice of material breach shall be deemed to not be effective
until the hearing has occurred, and that 3⁄4 of the all of the members of the Board determines not to change its position.
Minutes of the hearing shall be taken by a mutually acceptable independent person. For purposes of this Section 5.3, no act or
failure to act by the Chief Business Officer and General Counsel shall be considered “willful” if such act is done
by Chief Business Officer and General Counsel in the good faith belief that such act is or was in the best interests of the Company
or one or more of its businesses or was made upon advice of the Company’s counsel.

 

5.4.
Termination for Good Reason. The Chief Business Officer and General Counsel may terminate his consultancy prior to the
end of the Term, upon written notice to the Company, for Good Reason, which Good Reason is not remedied by the Company within
thirty (30) calendar days after written notice thereof by Chief Business Officer and General Counsel. The term “Good Reason”
shall include any of the following, (i) any assignment to Chief Business Officer and General Counsel of duties inconsistent with
Chief Business Officer and General Counsel’s position of Chief Business Officer and General Counsel or which constitute
a significant reduction in authority, responsibilities or status without his prior written consent; (ii) any demotion of his position
with the Company as Chief Business Officer and General Counsel without his written consent, including, but not limited to, reporting
to someone other than the Board; and (iii) any material reduction in Chief Business Officer and General Counsel’s Compensation.
or (iv) any attempted reduction of the terms of Chief Business Officer and General Counsel’s bonus.

 

5.5.
Termination by the Company other than For Cause or by Chief Business Officer and General Counsel for Good Reason.
If, other than as set forth in Section 10.1, the Chief Business Officer and General Counsel’s consultancy is terminated
during the Term by the Company other than For Cause and as approved by 3⁄4 of the board members and a 50% vote of the shareholders
or is terminated by Chief Business Officer and General Counsel for Good Reason, then the Company shall pay to Chief Business Officer
and General Counsel after such termination, subject to his execution of a standard release, severance payments (“Severance”)
equal to (i) twelve (12) months of Chief Business Officer and General Counsel’s Compensation for the year in which the termination
by Company for reasons other than For Cause or by Chief Business Officer and General Counsel for Good Reason occurs plus (ii)
the amount of the actual bonus earned by Chief Business Officer and General Counsel under Section 4.2(a) hereof for the year prior
to the year of such termination and for the first calendar year one hundred percent (100%) of the Target Cash Bonus. The Severance
shall be paid in a lump sum within thirty (30) days after the Release Effective Date (as defined below), less such deductions
as shall be required to be withheld by applicable law and regulations. In addition, if Chief Business Officer and General Counsel
timely and properly elects continuation coverage under the Consolidated Omnibus Reconciliation Act of 1985 (“COBRA”),
then, subject to his execution of a standard release, the Company shall reimburse Chief Business Officer and General Counsel for
the monthly COBRA premium paid by Chief Business Officer and General Counsel for Chief Business Officer and General Counsel and
Chief Business Officer and General Counsel’s eligible dependents. Chief Business Officer and General Counsel shall be eligible
to receive such reimbursement until the earliest of: (x) the twelve (12) month anniversary of the date of Chief Business Officer
and General Counsel’s termination of consultancy; (y) the date Chief Business Officer and General Counsel is no longer eligible
to receive COBRA continuation coverage; or (z) the date on which Chief Business Officer and General Counsel either receives or
becomes eligible to receive substantially similar coverage from another employer.

 

    	 	4	 

    	 

    

 

Section
6. Confidential Information; Restrictive Covenants.

 

6.1.
Disclosure. The Chief Business Officer and General Counsel hereby acknowledges that he will acquire access to Confidential
Information (as hereinafter defined) concerning the Company. For purposes hereof, “Confidential Information” shall
mean all information, documents and materials (regardless of the media in which maintained) concerning the Company, its business,
strategies, prospects, products, product development, formulas, research and development, know-how, names and contact information
of the Company’s customers, suppliers, contract manufacturers, vendors and other third-parties who do business with the
Company, and the Company’s current and future business plans, agreements to which the Company is a party or bound or are
in the process of negotiation, the Company’s financial information including information regarding its assets, liabilities,
results of operations financial condition, and any other information which a reasonable person would consider confidential or
proprietary to the Company. The Chief Business Officer and General Counsel acknowledges and agrees that the Confidential Information
is of great value to the Company, is the sole property of the Company, other than those customers, suppliers, contract manufacturers,
and vendors introduced to the Company by Chief Business Officer and General Counsel, and has been and will be acquired by him
in confidence. Confidential Information shall include all reports and analyses that use or are based upon any Confidential Information.

 

6.2.
Confidentiality. In consideration of the obligations undertaken by the Company herein, the Chief Business Officer and General
Counsel will not, at any time during or after the Term, directly or indirectly, use for Chief Business Officer and General Counsel’s
own benefit or any other party’s benefit, or reveal, divulge or make known to any third party, any Confidential Information
Company and not otherwise in the public domain. Confidential Information shall not include (i) information which was previously
known by the Chief Business Officer and General Counsel ; (ii) information which was given to Chief Business Officer and General
Counsel by any third party who at the time, to the knowledge of the Chief Business Officer and General Counsel (after reasonable
inquiry) was not under no obligation of confidentiality or a fiduciary obligation in favor of the Company; or (iii) is or becomes
publicly known other than due to a breach of this confidentiality covenant by the Chief Business Officer and General Counsel .
The Chief Business Officer and General Counsel may disclose Confidential Information that he is required to disclose as a result
of a governmental investigation, subpoena, applicable law or regulation or by a court order. The Chief Business Officer and General
Counsel shall cooperate to the extent legally permissible with the Company (at the cost and expense of the Company) should the
Company seek a protective order or other equitable relief with respect to any disclosure pursuant to the immediately preceding
sentence. If the Company does not seek such relief or waives compliance with this provision, the Chief Business Officer and General
Counsel shall nonetheless only disclose the Confidential Information that requires to be disclosed. The Parties hereto acknowledge
that pursuant to 18 USC § 1833(b), an individual may not be held liable under any criminal or civil federal or state trade
secret law for disclosure of a trade secret: (i) made in confidence to a government official, either directly or indirectly, or
to an attorney, solely for the purpose of reporting or investigating a suspected violation of law or (ii) in a complaint or other
document filed in a lawsuit or other proceeding, if such filing is made under seal. The Parties further acknowledge that an individual,
including the Chief Business Officer and General Counsel, suing an employer for retaliation based on the reporting of a suspected
violation of law may disclose a trade secret to his attorney and use the trade secret information in the court proceeding, so
long as any document containing the trade secret is filed under seal and the individual does not disclose the trade secret except
pursuant to court order.

 

6.3.
Restrictive Covenants. The Chief Business Officer and General Counsel recognizes that the services to be performed by him
hereunder are special, unique and extraordinary. The Parties confirm that it is reasonably necessary for the protection of the
Company that the Chief Business Officer and General Counsel agrees, and, accordingly, the Chief Business Officer and General Counsel
does hereby agree, that he will not, either on his own behalf or as an officer, director, stockholder, partner, principal, Chief
Business Officer and General Counsel , associate, employee, owner, agent, creditor, independent contractor, or co-venturer of
any third party or in any other relationship or capacity, directly or indirectly, at any time during his consultancy and for the
Restricted Period (as defined below) (i) solicit, induce, persuade or encourage, or attempt to solicit, induce, persuade or encourage,
any individual employed by, or consulting for, the Company and/or any Vice President or officer working for the Company, with
whom the Chief Business Officer and General Counsel has worked, to terminate such employee’s or consultancy’s position
with the Company, whether or not such employee or Vice President or officer or consultant is a full-time or temporary employee
or a consultant of the Company and whether or not such employement or consultancy is pursuant to a written agreement, for a determined
period, or at will or otherwise and (ii) engage, participate or invest in any business activity anywhere in the Region that develops,
manufactures or markets any products, or performs any services, that are otherwise competitive with or similar to the products
or services of the Company, or products or services that the Company or its affiliates or related entities (including entities
owned or controlled (in part or in total) by other persons having high level responsibilities for the Company (as employees or
consultants or otherwise) has under development or that are the subject of active planning at any time during the Restricted Period
(as defined below) provided that the forgoing shall not prohibit any possible investments by the Company in such affiliates or
related entities. The provisions of this Section 6.3 shall only apply to those individuals employed by or consulting for the Company
at the time of solicitation or attempted solicitation.

 

    	 	5	 

    	 

    

 

6.4.
Restricted Period. For purposes hereof, the term “Restricted Period” shall mean the Term and any period of
time thereafter during which the Chief Business Officer and General Counsel receives Severance or his regular Compensation and
benefits from the Company.

 

6.5.
Modification of Restrictions. If any of the restrictions contained in this Section 6 shall be deemed or determined by a
court of competent jurisdiction to be illegal or unenforceable by reason of the extent, duration or geographical scope thereof,
or otherwise, the Parties request that the court amend and “blue pencil” such restrictions so that they are modified
to be legal and enforceable to the fullest extent permissible.

 

Section
7. Work for Hire.

 

7.1.
The Chief Business Officer and General Counsel agrees to make full and prompt disclosure to the Company of all inventions, improvements,
discoveries, methods, developments, formulas, computer software (and programs and code) and works of authorship, whether or not
patentable or copyrightable, which were or are created, made, conceived or reduced to practice by Chief Business Officer and General
Counsel or under Chief Business Officer and General Counsel’s direction or jointly with others during Chief Business Officer
and General Counsel’s consultancy for the Company, whether or not during normal working hours or on the premises of the
Company (all of which are collectively referred to in this Agreement as “Developments”).

 

7.2.
The Chief Business Officer and General Counsel agrees to assign and, by executing this Agreement, Chief Business Officer and General
Counsel does hereby assign, to the Company (or to any person or entity designated by the Company) all of Chief Business Officer
and General Counsel’s right, title and interest, if any, in and to all Developments and all related patents, patent applications,
copyrights and copyright applications. However, this Section 7.2 shall not apply to Developments (i) which do not relate to the
present or planned business, operations, activities or research and development of the Company known by the Chief Business Officer
and General Counsel , and (ii) which are made and conceived by Chief Business Officer and General Counsel : (A) at a time other
than during normal working hours, (B) not on the Company’s premises and (C) not using the Company’s tools, devices,
equipment or proprietary information. Chief Business Officer and General Counsel understands that to the extent that the terms
of this Agreement shall be construed in accordance with the laws of any state which precludes a requirement in an consultancy
agreement to assign certain classes of inventions made by an employee, this Section 7 shall be interpreted not to apply to any
invention which a court rules and/or the Company agrees falls within such class or classes. The Chief Business Officer and General
Counsel also agrees to waive all claims to moral and/or equitable rights in any Developments.

 

7.3.
The Chief Business Officer and General Counsel agrees to cooperate fully at the Company’s expense with the Company acting
reasonably, both during and after Chief Business Officer and General Counsel’s consultancy with the Company, with respect
to the procurement, maintenance and enforcement of copyrights, patents and other intellectual property rights (both in the United
States and foreign countries) relating to Developments that are assigned to the Company pursuant to this Agreement. The Chief
Business Officer and General Counsel agrees that he will sign all papers, including, without limitation, copyright applications,
patent applications, declarations, oaths, formal assignments, assignments of priority rights, and powers of attorney, which the
Company may reasonably consider necessary or desirable in order to protect its right, title and interest in and to any Development.
The Chief Business Officer and General Counsel further agrees that if a court decision confirms the Company rights, title or interests
and the Company is unable, after a minimum of 3 direct contacts to the Chief Business Officer and General Counsel and reasonable
effort, to secure Chief Business Officer and General Counsel’s signature on any such papers, any Chief Business Officer
and General Counsel officer of the Company shall be entitled to execute any such papers as Chief Business Officer and General
Counsel’s agent and attorney-in-fact, and Chief Business Officer and General Counsel hereby irrevocably designates and appoints
each Chief Business Officer and General Counsel officer of the Company as Chief Business Officer and General Counsel’s agent
and attorney-in-fact to execute any such papers on Chief Business Officer and General Counsel’s behalf, and to take any
and all actions as the Company may deem necessary or desirable, in order to protect its rights and interests in any Development,
under the conditions described in this sentence. The designation and appointment of any such agent and attorney-in-fact shall
be strictly limited to the purposes described in this Section 7.3.

 

    	 	6	 

    	 

    

 

Section
8. Conflicts of Interest; Insider Trading.

 

8.1.
Conflicts of Interest. The Chief Business Officer and General Counsel agrees that he shall in order to avoid actual or
apparent conflicts of interest, except with the written consent of the Board, Chief Business Officer and General Counsel not have
any direct or indirect ownership or financial interest in any company, person or entity which is: (i) a service provider to, or
vendor of the Company; (ii) a customer of the Company; or (iii) a competitor of the Company. Chief Business Officer and General
Counsel shall not be deemed to have any direct or indirect ownership or financial interest for any such interest that does not
exceed five (5%) percent of the issued and outstanding voting equity securities of any class of any Company or other business
entity whose voting equity securities is traded on a national securities exchange or in the over-the-counter market.

 

8.2.
General Requirements. Chief Business Officer and General Counsel shall observe such lawful policies of the Company as may
from time to time be adopted by the Board and be in effect and notified to the Chief Business Officer and General Counsel . In
the performance of his duties on behalf of the Company, the Chief Business Officer and General Counsel will comply with all material
laws in all material respects.

 

8.3.
Insider Trading. The Chief Business Officer and General Counsel hereby agrees that Chief Business Officer and General Counsel
shall comply with Company any Insider Trading Policy from time to time adopted by the Company and in effect (the “Inside
Trading Policy”) and any and all federal, state and foreign securities laws, including, but not limited, to those that relate
to non-disclosure of information, insider trading and individual reporting requirements and shall specifically abstain from discussing
the non-public aspects of the Company’s business affairs with any individual or group of individuals (e.g., Internet chat
rooms) who does not have a business need to know such information for the benefit of the Company or in connection with the Company’s
business. The Chief Business Officer and General Counsel hereby agrees to immediately notify the Company’s General Counsel
in accordance with any Company Insider Trading Policy of the prior to Chief Business Officer and General Counsel’s acquisition
or disposition of any of the Company’s securities.

 

Section
9. Indemnification.

 

9.1.
Indemnification. The Company hereby agrees to indemnify and hold harmless the Chief Business Officer and General Counsel
(and his heirs, estate and personal representatives, if applicable) to the fullest extent permitted by, the Delaware General Company
Law or any other applicable law, as any or all may be amended from time to time. Such reimbursements shall include but not be
limited to Chief Business Officer and General Counsel’s reasonable and necessary out of pocket expenses including attorneys
and expert fees, losses, judgments, claims, and settlement payments and any other such costs and expenses. The indemnification
of the Company shall include any reasonable costs and expenses (including, without limitation, attorneys’ fees and expenses)
incurred by the Chief Business Officer and General Counsel in attempting to enforce his indemnification rights against the Company.

 

9.2.
Undertaking. To the extent that the Company advances payment for any fees or expenses to the Chief Business Officer and
General Counsel pursuant to this Section 9, such advance shall be accompanied by a written undertaking by the Chief Business Officer
and General Counsel to repay such amounts if it shall be ultimately determined by a court of competent jurisdiction in a final
disposition, that the Chief Business Officer and General Counsel (i) is not entitled to be indemnified by the Company or (ii)
that the amount advanced exceeded the indemnification to which he is entitled, in which case the amount of such excess shall be
repaid to the Company.

 

9.3.
Notice. As a condition precedent to his right to be indemnified hereunder, the Chief Business Officer and General Counsel
shall give the Company notice in writing as soon as practicable of any claim made against him for which indemnity will or reasonably
could be sought under this Agreement. Promptly after receiving the notice from the Chief Business Officer and General Counsel
, the Company shall inform the Chief Business Officer and General Counsel in writing if the Company is providing indemnification
for the claim.

 

    	 	7	 

    	 

    

 

9.4.
Cooperation. Chief Business Officer and General Counsel shall fully cooperate with all lawful and reasonable request the
Company in connection with any matter for which the Chief Business Officer and General Counsel has made a claim for indemnification
hereunder and the Company has acknowledged is obligation with respect to such claim. The Company shall be entitled at its own
expense to participate in the defense of any proceeding, claim or action, or, if it shall elect, to assume control such defense,
in which event such defense shall be conducted by counsel chosen by the Company, subject to the consent of the Chief Business
Officer and General Counsel, which consent shall not be unreasonably withheld or delayed. For purpose of clarification, if the
Company does not assume control of the defense of the claim, the cost and expenses of legal counsel and the other costs and expenses
incurred by the Chief Business Officer and General Counsel in defending the claim shall be paid by the Company, as incurred, as
part of the Company’s indemnification obligation.

 

9.5.
Exceptions. The Company shall not be obligated under this Agreement to make any payment for any claim which the Chief Business
Officer and General Counsel has sought indemnification:

 

(a)
For which payment is actually made to the Chief Business Officer and General Counsel under valid and collectable insurance policies,
the premiums of which are paid by the Company or any of its affiliates, except in respect of any deductible that is charged to
the Company and excess beyond the policy payment limit under such insurance;

 

(b)
For which Chief Business Officer and General Counsel is indemnified by the Company otherwise than pursuant to this Agreement,
provided such amount has previously been paid to Chief Business Officer and General Counsel or a third party making the claim;

 

(c)
Brought about or contributed to by the dishonesty or willful misconduct of Chief Business Officer and General Counsel as established
by final and non- appealable determination by a court of competent jurisdiction; or

 

(d)
For which Chief Business Officer and General Counsel fails to cooperate, if the claim involves or relates to a criminal or civil
investigation brought by any legal authority or regulatory body.

 

9.6
D&O Insurance. To the extent available in accordance with reasonable commercial rates, the Company shall maintain in
effect, a Director’s and Officer’s liability insurance policy that covers the directors and officers of the Company,
upon terms and provisions and in amounts (including deductibles) that are comparable to public companies of the relative size
of the Company and in the same general industry as the Company, The policy shall be an occurrence based policy for the matters
that are subject to its coverage.

 

Section
10. Change in Control.

 

10.1.
Payment on Change in Control Termination. The Company will provide or cause to be provided to the Chief Business Officer
and General Counsel the rights and benefits described below if, during the Term, within the three (3) month period prior to, or
within the twelve (12) month period following, a Change in Control, (x) the Chief Business Officer and General Counsel terminates
his consultancy for Good Reason, or (y) the Company or its successor terminates Chief Business Officer and General Counsel’s
consultancy (“Change in Control Termination”); provided however, that a Change in Control Termination shall not include
a termination For Cause or without or for Good Reason or a termination as a result of Chief Business Officer and General Counsel’s
death or Total Disability. In the event of a Change in Control Termination during the Term, the Company shall pay or cause its
successor to pay to Chief Business Officer and General Counsel , in cash, in a lump sum within thirty (30) days after such termination,
less such deductions as shall be required to be withheld by applicable law and regulations, and subject to his execution of a
standard release, an amount equal to two (2) times Chief Business Officer and General Counsel’s annual Compensation on the
day preceding the Change in Control Termination, plus (ii) an amount equal to the aggregate bonus received by Chief Business Officer
and General Counsel for the year immediately preceding the Change in Control Termination and for the first calendar year one hundred
percent (100%) of the Target Cash Bonus. In addition, if Chief Business Officer and General Counsel timely and properly elects
continuation coverage under COBRA, then, subject to his execution of standard release, the Company shall reimburse Chief Business
Officer and General Counsel for the monthly COBRA premium paid by Chief Business Officer and General Counsel for officer and executive’s
eligible dependents. Chief Business Officer and General Counsel shall be eligible to receive such reimbursement until the earliest
of: (x) the eighteen (18) month anniversary of the date of Executive’s termination of consultancy; (y) the date Chief Business
Officer and General Counsel is no longer eligible to receive COBRA continuation coverage; or (z) the date on which Chief Business
Officer and General Counsel either receives or becomes eligible to receive substantially similar coverage from another employer.
In addition, in the event of a Change in Control Termination, subject to Chief Business Officer and General Counsel’s execution
of a standard release, any and all outstanding stock options held by Chief Business Officer and General Counsel shall become fully
vested and exercisable. Chief Business Officer and General Counsel shall have six (6) months to exercise any such stock options
following his termination of consultancy, provided that in no event may Chief Business Officer and General Counsel exercise a
stock option following the original expiration date of such stock option as set forth in the applicable award agreement.

 

    	 	8	 

    	 

    

 

10.2.
Change in Control Defined. A “Change in Control” shall be deemed to occur upon the earliest to occur after
the date of this Agreement of any of the following events;

 

(a)
Any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”)) becomes the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly
or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by
the Company’s then-outstanding voting securities;

 

(b)
The consummation of the sale or disposition by the Company of all or substantially all of the Company’s assets;

 

(c)
The consummation of a merger or consolidation of the Company with or into any other entity, other than a merger or
consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to
represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its
parent) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such
surviving entity or its parent outstanding immediately after such merger or consolidation.

 

Notwithstanding
anything contained herein to the contrary, to the extent required in order to avoid accelerated taxation, a transaction shall
not constitute a Change in Control if its sole purpose is to change the state of the Company’s or to create a holding company
that will be owned in substantially the same proportions by the persons who held the Company’s voting securities immediately
before such transaction or in any case of investments by the Company in affiliates or related entities, including entities owned
or controlled (in part or in total) by other persons having high level responsibilities for the Company (as employees or Chief
Business Officer and General Counsel s or otherwise).

 

Section
11. Miscellaneous.

 

11.1.
Relationship of the Parties. Chief Business Officer and General Counsel’s relationship with Company will be that
of an independent contractor, and Chief Business Officer and General Counsel will not be an employee of Company or considered
to be such an employee for any purpose whatsoever. For the avoidance of doubt, Chief Business Officer and General Counsel will
be solely responsible for making appropriate filings and payments to all applicable taxing and social security authorities, including
payments of all withholding and payroll taxes due on compensation received under this Agreement.

 

11.2
Limitation of Liability. Notwithstanding anything contained herein to the contrary, Chief Business Officer and General Counsel’s
total liability arising under or in connection with this Agreement, whether arising in contract, tort (including negligence) or
restitution, or for breach of statutory duty or misrepresentation, or otherwise, shall in all circumstances be limited to the
amount of compensation payable over the current year. Notwithstanding anything to the contrary in this Agreement, the foregoing
limitations on damages will not be applicable to damages which arise out of the fraud or willful misconduct of a Party.

 

    	 	9	 

    	 

    

 

11.3
Section 409A. The Parties intend for the payments and benefits under this Agreement are to be exempt from Section 409A
of the Internal Revenue Code of 1986, as amended (“Section 409A”), or, if not so exempt, to be paid or provided in
a manner which complies with the requirements of said Section 409A, and intend that this Agreement shall be construed and administered
in accordance with such intention. Any payments that qualify for the “short-term deferral” exception or another exception
under Section 409A shall be paid under the applicable exception. For purposes of the limitations on nonqualified deferred compensation
under Section 409A, each payment of compensation under this Agreement shall be treated as a separate payment of compensation.
All in-kind benefits, reimbursements, and tax-gross-ups (if any) to be provided under this Agreement shall be made or provided
in accordance with the requirements of Section 409A of the Code, including, where applicable, the requirements that (x) the amount
of expenses eligible for reimbursement, or in kind benefits provided, during a calendar year may not affect the expenses eligible
for reimbursement, or in kind benefits to be provided, in any other calendar year, (y) the reimbursement of an eligible expense
will be made no later than the last day of the calendar year following the year in which the expense is incurred, and (z) the
right to reimbursement or in kind benefits is not subject to liquidation or exchange for another benefit. Notwithstanding anything
contained herein to the contrary, to the extent required in order to avoid accelerated taxation and/or tax penalties under Section
409A, (i) no amounts payable under this Agreement to the Chief Business Officer and General Counsel on termination of consultancy
shall be paid until the Chief Business Officer and General Counsel would be considered to have incurred a separation from service
from the Company within the meaning of Section 409A and (ii) amounts that would otherwise be payable and benefits that would otherwise
be provided pursuant to this Agreement during the Applicable Period (as defined below) shall instead be paid on the first business
day after the expiration of the Applicable Period, with interest from the date such amounts would otherwise have been paid at
the short-term applicable federal rate, compounded semi-annually, as determined under Section 1274 of the Internal Revenue Code
of 1986, as amended, for the month in which payment would have been made but for the delay in payment required to avoid the imposition
of an additional rate of tax on Chief Business Officer and General Counsel under Section 409A. For purposes hereof, the term “Applicable
Period” shall be the period commencing on Chief Business Officer and General Counsel’s separation from service with
the Company and ending on the date that is six (6) months following Chief Business Officer and General Counsel’s separation
from service.

 

11.5.
Survival. The provisions of Sections 5, 6.1, 6.2, 6.4, 6.5, 7.3, 8, 9, 10 and 11 shall indefinitely survive Chief Business
Officer and General Counsel’s consultancy with the Company. The provisions of Section 6.3 shall survive for the Restricted
Period, as defined therein.

 

11.6.
Entire Agreement; Amendment; Waiver. This Agreement constitutes and embodies the entire and complete understanding and
agreement of the Parties with respect to Chief Business Officer and General Counsel’s consultancy for the Company, supersedes
all prior and/or contemporaneous understandings and agreements, if any, whether oral or written, between Chief Business Officer
and General Counsel and the Company, with respect to that subject matter, all of which are merged herein. This Agreement may not
be amended, modified, waived or changed except by an instrument in writing executed by each of the Parties. Any waiver of any
provision of this Agreement shall be limited to the instance and purpose for which it is given. No course of dealing between the
Parties shall be deemed to be an amendment or waiver or any term or provision of this Agreement. No waiver by either party of
any provision or condition to be performed shall be deemed a waiver of similar or dissimilar provisions or conditions at the same
or any prior or subsequent time.

 

11.7.
Assignment; Binding Effect. This Chief Business Officer and General Counsel may not assign or delegate any of his or duties
under this Agreement. Any attempted assignment or delegation shall be null and void ab initio. This Agreement shall inure to the
benefit of, be binding upon and enforceable against, the Parties hiseto and their respective successors and permitted assigns.

 

11.8.
Captions. The captions/headings contained in this Agreement are for convenience of reference only and shall not affect
in any way the meaning, construction or interpretation of this Agreement.

 

11.9
Language. The text in English will constitute the only authentic text of the agreement between the Parties.

 

11.10
Publicity. If and when appropriate in the view of both Parties, the Parties may make any announcement concerning the existence
of this Agreement and the fact that Company has retained the services of Chief Business Officer and General Counsel. The Parties
shall not disclose the terms and conditions of this Agreement, without the prior written consent of the other party, unless such
disclosure is required by law.

 

    	 	10	 

    	 

    

 

11.11
Notices. All notices, requests, demands and other communications required or permitted to be given hereunder shall be in
writing and shall be deemed to have been duly given on the business day when personally delivered or on the business day when
received, if sent by a recognized overnight courier service or by certified, mail, postage prepaid, to the Party at the address
for such Party set forth on Schedule 1 attached hereto or to such other address as either Party may hereafter give notice of to
the other Party in accordance with the provisions hereof. Invoices of the Chief Business Officer and General Counsel may be sent
to the Company via e-mail and are deemed as an original.

 

11.12.
Governing Law; Jurisdiction. This Agreement shall be governed by and interpreted under the laws of the State of New York
applicable to contracts made and to be performed therein without giving effect to the principles of conflict of laws thereof which
could result in the application of the laws of another jurisdiction. The Parties hereby irrevocably consent to the exclusive jurisdiction
of the United States Federal Courts located in the Southern District of the State of New York or the courts of the State of New
York located in New York County with respect to any action, suit or proceeding arising out of or relating to this Agreement and
the transactions contemplated hereby. By its execution hereof, the Parties hereby irrevocably waive any objection and any right
of immunity on the ground of venue, the convenience of the forum or the jurisdiction of said courts or from the execution of judgments
resulting there from. The parties hereby irrevocably accept and submit to the jurisdiction of the aforesaid courts in any such
suit, action or proceeding.

 

11.13.
Waiver of Jury Trial. THE PARTIES hereby IRREVOCABLY AND WILLINGLY WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT
OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY, WHETHER NOW EXISTING OR HEREAFTER
ARISING, AND WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE. THE PARTIES AGREE THAT ANY OF THEM MAY FILE A COPY OF THIS PARAGRAPH
WITH ANY COURT AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY AND BARGAINED-FOR AGREEMENT AMONG THE PARTIES IRREVOCABLY TO WAIVE
TRIAL BY JURY AND THAT ANY ACTION OR PROCEEDING WHATSOEVER BETWEEN THEM RELATING TO THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED
HEREBY SHALL INSTEAD BE TRIED IN A COURT OF COMPETENT JURISDICTION BY A JUDGE SITTING WITHOUT A JURY.

 

11.11.
Counterparts. This Agreement may be executed and delivered in counterparts, including by facsimile transmission or portable
document format (“.pdf”), each of which shall be deemed an original, but all of which together shall constitute one
and the same instrument.

 

Signature
page follows

 

    	 	11	 

    	 

    

 

IN
WITNESS WHEREOF, each of the Parties hereto have executed this Agreement as of the date set forth above.

 

For
Vector Therapeutics Inc.

 

By:
Daniel Teper

Chief
Executive Officer

 

 

By:
Daniel Teper

 

November
7, 2018

 

Read
and acknowledged

 

    	 	12	 

    	 

    

 

The
Chief Business Officer and General Counsel 

 

 

By:
Alexandre Mencik

 

November
7, 2018

 

Read
and acknowledged

 

    	 	13Exhibit

Exhibit 10.1

AMENDED AND RESTATED
SPECTRUM PHARMACEUTICALS, INC. 
2009 EMPLOYEE STOCK PURCHASE PLAN
This EMPLOYEE STOCK PURCHASE PLAN (the “Plan”) is hereby established by Spectrum Pharmaceuticals, Inc., a Delaware corporation (the “Company”) as of March 23, 2009.  The Plan was amended and restated as of September 21, 2018.
ARTICLE I
PURPOSE OF THE PLAN
1.1    Purpose.  The Company has determined that it is in its best interests to provide an incentive to attract and retain employees and to increase employee morale by providing a program through which employees may acquire a proprietary interest in the Company through the purchase of shares of the common stock of the Company (“Company Stock”).  The Plan is hereby established by the Company to permit employees to subscribe for and purchase directly from the Company shares of the Company Stock at a discount from the market price, and to pay the purchase price in installments by payroll deductions.  The Plan is intended to qualify as an “employee stock purchase plan” under Section 423 of the Internal Revenue Code of 1986, as amended from time to time (the “Code”).  The provisions of the Plan are to be construed in a manner consistent with the requirements of Section 423 of the Code.  The Plan is not intended to be an employee benefit plan under the Employee Retirement Income Security Act of 1974, and therefore is not required to comply with that Act.
ARTICLE II
DEFINITIONS
2.1    Compensation.  “Compensation” means the (i) regular base salary paid to a Participant by the Company during such individual’s period of participation in one or more Offering Periods under the Plan before (ii) any pre-tax contributions made by the Participant to any Code Section 401(k) salary deferral plan or any Code Section 125 cafeteria benefit program now or hereafter established by the Company or any of its affiliates.  The following items of compensation shall be included in Compensation: all (i) overtime payments, commissions that function as base salary equivalents, vacation and sick leave compensation and bonuses.  The following items of compensation shall not be included in Compensation: (i) commissions that do not function as base salary equivalents, (ii) profit-sharing distributions (iii) incentive compensation and incentive payments and (iv) any and all contributions (other than Code Section 401(k) or Code Section 125 contributions) made on the Participant’s behalf by the Company or any of its affiliates under any employee benefit or welfare plan now or hereafter established.
2.2    Employee.  “Employee” means each person currently employed by the Company or any of its operating subsidiaries, any portion of whose income is subject to withholding of income tax or for whom Social Security retirement contributions are made by the Company or any of its operating subsidiaries.
2.3    5% Owner.  “5% Owner” means an Employee who, immediately after the grant of any rights under the Plan, would own Company Stock or hold outstanding options to purchase Company Stock possessing 5% or more of the total combined voting power of all classes of stock of the Company.  For purposes of this Section, the ownership attribution rules of Code Section 425(d) shall apply.
2.4    Offering Date.  “Offering Date” means the first day of each Offering Period under the Plan.  For the first Offering Period, the Offering Date shall be July 1, 2009.

2.5    Participant.  “Participant” means an Employee who has satisfied the eligibility requirements of Section 3.1 and has become a participant in the Plan in accordance with Section 3.2.
2.6    Plan Year.  “Plan Year” means the twelve consecutive month period ending on December 31.
2.7    Offering Period.  “Offering Period” means consecutive periods to be set by the Administrator.  However, the first Offering Period shall commence on July 1, 2009 and end December 31, 2009.
2.8    Purchase Date.  “Purchase Date” means the last day of each Offering Period.
ARTICLE III 
ELIGIBILITY AND PARTICIPATION
3.1    Eligibility.  Each Employee of the Company or any of its operating subsidiaries designated from time to time by the Administrator, who may become a Participant in the Plan on the Offering Date coincident with or next following his satisfaction of such requirements of employment with the Company or any of its operating subsidiaries.  The Administrator may exclude from participation those persons allowed to be excluded pursuant to Code Section 423, provided that such exclusions shall apply to all employees who meet the exclusion criteria.  The Administrator may provide that Employees who are “highly compensated employees” within the meaning of Section 423(b)(4)(D) of the Code are not eligible to participate in the Plan.
3.2    Participation.  An Employee who has satisfied the eligibility requirements of Section 3.1 may become a Participant in the Plan upon his or her completion and delivery to the Human Resources Department of the Company of a subscription agreement provided by the Company (the “Subscription Agreement”) authorizing payroll deductions.  Payroll deductions for a Participant shall commence on the Offering Date coincident with or next following the filing of the Participant’s Subscription Agreement and shall remain in effect until revoked by the Participant by the filing of a notice of withdrawal from the Plan under Article VIII or by the filing of a new Subscription Agreement providing for a change in the Participant’s payroll deduction rate under Section 5.2.
3.3    Special Rules.  Under no circumstances shall:
(a)    A 5% Owner be granted a right to purchase Company Stock under the Plan; or
(b)    A Participant be entitled to purchase Company Stock under the Plan which, when aggregated with all other employee stock purchase plans of the Company, exceeds an amount equal to the Aggregate Maximum.  “Aggregate Maximum” means an amount equal to twenty-five thousand dollars ($25,000) worth of Company Stock (determined using the fair market value of such Company Stock at each applicable Offering Date) during each Plan Year.
(c)    The number of shares of Company Stock purchasable by a Participant on any Purchase Date exceed 50,000 shares, subject to necessary adjustments under Section 10.4.
ARTICLE IV 
OFFERING PERIODS
The initial grant of the right to purchase Company Stock under the Plan shall commence on July 1, 2009 and terminate on the next Purchase Date.  Thereafter, the Plan shall provide for Offering Periods commencing on each Offering Date and terminating on the next following Purchase Date.
ARTICLE V 
PAYROLL DEDUCTIONS

5.1    Participant Election.  Each Participant shall designate, in a subscription agreement, the amount of payroll deductions to be made from his or her paycheck to purchase Company Stock under the Plan.  The amount so designated within the Subscription Agreement shall be effective as of the next Offering Date and shall continue until terminated or altered in accordance with Section 5.2 below.
5.2    Changes in Election.  A Participant may terminate participation in the Plan at any time prior to the close of an Offering Period as provided in Article VIII.  A Participant may decrease or increase the rate of payroll deductions at any time during any Offering Period by completing and delivering to the Human Resources Department of the Company a new Subscription Agreement setting forth the desired change.  A Participant may also terminate payroll deductions and have accumulated deductions for the Offering Period up to the date of termination applied to the purchase of Company Stock as of the next Purchase Date by completing and delivering to the Human Resources Department a new Subscription Agreement setting forth the desired change.  Any change under this Section shall become effective on the next payroll period (to the extent practical under the Company’s payroll practices) following the delivery of the new Subscription Agreement.
5.3    Participant Accounts.  The Company shall establish and maintain a separate journal account (“Account”) for each Participant.  The amount of each Participant’s payroll deductions shall be credited to his or her Account.  No interest will be paid or allowed on amounts credited to a Participant’s Account.  All payroll deductions received by the Company under the Plan are general corporate assets of the Company and may be used by the Company for any corporate purpose.  The Company is not obligated to segregate such payroll deductions.
ARTICLE VI 
GRANT OF PURCHASE RIGHTS
6.1    Right to Purchase Shares.  On each Offering Date, each Participant shall be granted a right to purchase at the price determined under Section 6.2 that number of whole shares of Company Stock that can be purchased or issued by the Company based upon that price with the amounts held in his or her Account, subject to the limits set forth in Section 3.3.
6.2    Purchase Price.  The purchase price for any Offering Period shall be the lesser of:
(a)    85% of the Fair Market Value of Company Stock on the Offering Date; or
(b)    85% of the Fair Market Value of Company Stock on the Purchase Date.
6.3    Fair Market Value.  “Fair Market Value” means the value of one share of Company Stock, determined as follows:
(a)    If the Company Stock is then listed or admitted to trading on a stock exchange which reports closing sale prices, the Fair Market Value shall be the closing sale price on the date of valuation on the principal stock exchange on which the Company Stock is then listed or admitted to trading, or, if no closing sale price is quoted or no sale takes place on such day, then the Fair Market Value shall be the closing sale price of the Company Stock on such exchange on the immediately preceding day on which a sale occurred.
(b)    If the Company Stock is not then listed or admitted to trading on a stock exchange which reports closing sale prices, the Fair Market Value shall be the average of the closing bid and asked prices of the Company Stock in the over-the-counter market on the date of valuation.
(c)    If neither (a) nor (b) is applicable as of the date of valuation, then the Fair Market Value shall be determined by the Administrator (defined in Section 9.1(a) below) in good faith using any reasonable method of valuation, which determination shall be conclusive and binding on all interested parties.

ARTICLE VII 
PURCHASE OF STOCK
7.1    Purchase of Company Stock.  Absent an election by the Participant to terminate and have his or her Account returned, on each Purchase Date, the Plan shall purchase on behalf of each Participant the maximum number of whole shares of Company Stock at the purchase price determined under Section 6.2 above as can be purchased with the amounts held in each Participant’s Account.  The Plan shall not be required to purchase any fractional shares of Company Stock.  In the event that there are amounts held in a Participant’s Account that are not used to purchase Company Stock, all such amounts shall be held in the Participant’s Account and carried forward to the next Offering Period, or may be returned to the Participant at his or her election.
7.2    Delivery of Company Stock.
(a)    Company Stock acquired under the Plan may either be issued directly to Participants or may be issued to a contract administrator (the “Agent”) engaged by the Administrator under Article IX to carry out responsibilities under the Plan.  If the Company Stock is issued in the name of the Agent, all Company Stock so issued (“Plan Held Stock”) shall be held in the name of the Agent for the benefit of the Plan.  The Agent shall maintain accounts for the benefit of the Participants which shall reflect each Participant’s interest in the Plan Held Stock.  Such accounts shall reflect the number of shares of Company Stock that are being held by the Agent for the benefit of each Participant.
(b)    Any Participant may elect to have the Company Stock purchased under the Plan from his or her Account be issued directly to the Participant.  Any election under this paragraph shall be on the forms provided by the Company and shall be issued in accordance with paragraph (c) below.
(c)    In the event that Company Stock under the Plan is issued directly to a Participant, the Company will deliver to each Participant a number of shares of Company Stock purchased promptly after the Purchase Date.  Shares shall be delivered either in certificated form, or otherwise, as elected by the Company in the exercise of its reasonable discretion and subject to applicable law.  The time of issuance and delivery of shares may be postponed for such period as may be necessary to comply with the registration requirements under the Securities Act of 1933, as amended, the listing requirements of any securities exchange on which the Company Stock may then be listed, or the requirements under other laws or regulations applicable to the issuance or sale of such shares.
ARTICLE VIII 
WITHDRAWAL
8.1    In Service Withdrawals.  At any time prior to the Purchase Date of an Offering Period, any Participant may withdraw the amounts held in his Account by executing and delivering to the Human Resources Department for the Company written notice of withdrawal on the form provided by the Company.  In such a case, the entire balance of the Participant’s Account shall be paid to the Participant, without interest, as soon as is practicable.  Upon such notification, the Participant shall not participate in the Plan for the remainder of the Offering Period in which the notice is given, but may then be reinstated as a Participant for a subsequent Offering Period by executing and delivering a new Subscription Agreement to the Company.
8.2    Termination of Employment.
(a)    In the event that a Participant’s employment with the Company terminates for any reason, or ceases to be eligible under Section 3.1, the Participant shall cease to participate in the Plan on the date of termination.  As soon as is practical following the date of termination, the entire balance of the Participant’s Account shall be paid to the Participant or his beneficiary, without interest.
(b)    A Participant may file a written designation of a beneficiary who is to receive any shares of Company Stock purchased under the Plan or any cash from the Participant’s Account in the event of his or her 

death subsequent to a Purchase Date, but prior to delivery of such shares and cash.  In addition, a Participant may file a written designation of a beneficiary who is to receive any cash from the Participant’s Account under the Plan in the event of his death prior to a Purchase Date under paragraph (a) above.
(c)    Any beneficiary designation under paragraph (b) above may be changed by the Participant at any time by written notice.  In the event of the death of a Participant, the Company may rely upon the most recent beneficiary designation it has on file as being the appropriate beneficiary.  In the event of the death of a Participant, and no valid beneficiary designation exists or the beneficiary has predeceased the Participant, the Company shall deliver any cash or shares of Company Stock to the executor or administrator of the estate of the Participant, or if no such executor or administrator has been appointed to the knowledge of the Company, the Company, in its sole discretion, may deliver such shares of Company Stock or cash to the spouse or any one or more dependents or relatives of the Participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate.
ARTICLE IX 
PLAN ADMINISTRATION.
9.1    Plan Administration.
(a)    Authority to control and manage the operation and administration of the Plan shall be vested in the Board of Directors of the Company, or a committee thereof (herein referred to as the “Administrator”).  The Administrator shall have all powers necessary to supervise the administration of the Plan and control its operations.
(b)    In addition to any powers and authority conferred on the Administrator elsewhere in the Plan or by law, the Administrator shall have the following powers and authority:
(i)    To determine when and how rights to purchase common stock are granted and the terms and conditions of each offering;
(ii)    To designate from time to time which of the Company’s designated subsidiaries are eligible to participate in the Plan;
(iii)    To construe and interpret the Plan and the rights offered under the Plan;
(iv)    To establish, amend and revoke rules and regulations for the administration of the Plan;
(v)    To amend, suspend or terminate the Plan; provided, however that the Administrator may not amend the Plan to either increase the number of shares that may be purchased under the Plan or to change the designation or class of Employees eligible to participate in the Plan without obtaining stockholder approval within 12 months before or after such action if such approval is required by applicable laws, codes, or regulations; and
(vi)    To exercise such other powers and perform such other acts deemed necessary to carry out the intent of the Plan.
(c)    Any action taken in good faith by the Administrator in the exercise of authority conferred upon it by this Plan shall be conclusive and binding upon a Participant and his or her beneficiaries.  All discretionary powers conferred upon the Administrator shall be absolute.
9.2    Limitation on Liability.  No Employee of the Company or member of the Administrator shall be subject to any liability with respect to his duties under the Plan unless the person acts fraudulently or in bad faith.  To the extent permitted by law, the Company shall indemnify each member of the Administrator, and any other Employee of the Company with duties under the Plan who was or is a party, or is threatened to be made a 

party, to any threatened, pending or completed proceeding, whether civil, criminal, administrative, or investigative, by reason of the person’s conduct in the performance of his duties under the Plan.
ARTICLE X 
COMPANY STOCK
10.1    Limitations on Purchase of Shares.  The maximum number of shares of Company Stock that shall be made available for future sale under the Plan shall be Five Million (5,000,000) shares plus an annual increase to be added on January 1 of each calender year beginning January 1, 2010 equal to the lesser of (i) 1,000,000 shares or (ii) an amount determined by the Administrator.  Provided however, that in no event should the number of shares of Company Stock available for future sale under the 2009 ESPP exceed 10,000,000.  The shares of Company Stock to be sold to Participants under the Plan will be either purchased in broker’s transactions in accordance with the requirements of federal securities laws or issued by the Company.  If the total number of shares of Company Stock that would otherwise be issuable or purchasable pursuant to rights granted pursuant to Section 6.1 of the Plan at the Purchase Date exceeds the number of shares then available under the Plan, the Company shall make a pro rata allocation of the shares remaining available in as uniform and equitable a manner as is practicable.  In such event, the Company shall give written notice of such reduction of the number of shares to each participant affected thereby and any unused payroll deductions shall be returned to such participant if necessary.
10.2    Voting Company Stock.  The Participant will have no interest or voting right in shares to be purchased under Section 6.1 of the Plan until such shares have been purchased.
10.3    Registration of Company Stock.  Shares to be delivered to a Participant under the Plan will be registered in the name of the Participant unless designated otherwise by the Participant.
10.4    Changes in Capitalization of the Company.  Subject to any required action by the stockholders of the Company, the number of shares of Company Stock covered by each right under the Plan which has not yet been exercised and the number of shares of Company Stock which have been authorized for issuance under the Plan but have not yet been placed under rights or which have been returned to the Plan upon the cancellation of a right, as well as the Purchase Price per share of Company Stock covered by each right under the Plan which has not yet been exercised, shall be proportionately adjusted for any increase or decrease in the number of issued shares of Company Stock resulting from a stock split, stock dividend, spin-off, reorganization, recapitalization, merger, consolidation, exchange of shares or the like.  Such adjustment shall be made by the Board of Directors of the Company, whose determination in that respect shall be final, binding and conclusive.  Except as expressly provided herein, no issue by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Company Stock subject to any right granted hereunder.
10.5    Merger, Liquidation or Dissolution of Company.  In the event of: (1) the Company’s dissolution or liquidation, (2) a merger or consolidation in which the Company is not the surviving corporation; (3) a reverse merger in which the Company is the surviving corporation but the shares of common stock outstanding immediately preceding the merger are converted by virtue of the merger into other property, whether in the form of securities, cash or otherwise; or (4) the acquisition by any person, entity or group of the beneficial ownership of the Company’s securities representing at least 50% of the combined voting power entitled to vote in the election of directors, then, as determined by the Administrator in its sole discretion (i) any surviving or acquiring corporation may assume outstanding rights or substitute similar rights for those under the Plan, (ii) such rights may continue in full force and effect, or (iii) Participants’ accumulated payroll deductions may be used to purchase common stock immediately prior to the transaction described above (at a Purchase Date to be chosen solely by the Administrator) and the Participants’ rights under the ongoing offering period are terminated.
ARTICLE XI 
MISCELLANEOUS MATTERS

11.1    Amendment and Termination.  The Plan will become effective upon the later to occur of its adoption by the Board or its approval by the stockholders of the Company.  Since future conditions affecting the Company cannot be anticipated or foreseen, the Company reserves the right to amend, modify, or terminate the Plan at any time.  Upon termination of the Plan, all benefits shall become payable immediately.  Notwithstanding the foregoing, no such amendment or termination shall affect rights previously granted, nor may an amendment make any change in any right previously granted which adversely affects the rights of any Participant.  In addition, to the extent required by applicable laws, codes or regulations, no amendment may be made without obtaining stockholder approval within 12 months before or after such action if such amendment would,
(a)    Increase the number of shares of Company Stock that may be issued under the Plan; or
(b)    Change the designation or class of employees eligible to participate in the Plan.
11.2    Stockholder Approval.  Continuance of the Plan and the effectiveness of any right granted hereunder shall be subject to approval by the stockholders of the Company, within twelve months before or after the date the Plan is adopted by the Board of Directors of the Company.
11.3    Benefits Not Alienable.  Rights and benefits under the Plan may not be assigned or alienated, whether voluntarily or involuntarily.  Any attempt at assignment, transfer, pledge or other disposition shall be without effect, except that the Company may treat such act as an election to withdraw funds in accordance with Article VIII.
11.4    No Enlargement of Employee Rights.  This Plan is strictly a voluntary undertaking on the part of the Company and shall not be deemed to constitute a contract between the Company and any Employee or to be consideration for, or an inducement to, or a condition of, the employment of any Employee.  Nothing contained in the Plan shall be deemed to give the right to any Employee to be retained in the employ of the Company or to interfere with the right of the Company to discharge any Employee at any time.
11.5    Governing Law.  To the extent not preempted by Federal law, all legal questions pertaining to the Plan shall be determined in accordance with the laws of the State of California without regard for conflicts of laws principles.
11.6    Non-business Days.  When any act under the Plan is required to be performed on a day that falls on a Saturday, Sunday or legal holiday, that act shall be performed on the next succeeding day which is not a Saturday, Sunday or legal holiday.  Notwithstanding the above, Fair Market Value shall be determined in accordance with Section 6.3.
11.7    Compliance With Securities Laws.  Notwithstanding any provision of the Plan, the Administrator shall administer the Plan in such a way to insure that the Plan at all times complies with any requirements of Federal Securities Laws.  For example, affiliates may be required to make irrevocable elections in accordance with the rules set forth under Section 16b-3 of the Securities Exchange Act of 1934.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}]]